List view / Grid view

Novo Nordisk

 

news

NHS Scotland approves Novo Nordisk’s diabetes drug

9 August 2016 | By Novo Nordisk

The drug was approved using evidence from three phase III studies in adults with type 1 diabetes mellitus and five phase III studies in adults with type 2 diabetes mellitus. The researchers discovered that insulin degludec was non-inferior to other long-acting insulin analogues, assessed by the mean change in glycosylated…